Mouton, A. https://orcid.org/0000-0003-2753-0872
Blanc, F.
Gros, A.
Manera, V.
Fabre, R.
Sauleau, E.
Gomez-Luporsi, I.
Tifratene, K.
Friedman, L.
Thümmler, S.
Pradier, C.
Robert, P. H.
David, R.
Funding for this research was provided by:
French ministry of health
Article History
Received: 8 February 2018
Accepted: 31 July 2018
First Online: 12 September 2018
Ethics approval and consent to participate
: This study was conducted in accordance with the Declaration of Helsinki. According to the French law, no consent was required, because this study is based on an anonymized database. We checked the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement in drafting the paper [].
: Not applicable.
: PHR reports no financial relationships with commercial interests. CP reports no financial relationships with commercial interests. FB reports no financial relationships with commercial interests. IGL reports no financial relationships with commercial interests. AM reports no financial relationships with commercial interests. ST reports no financial relationships with commercial interests. ES reports no financial relationships with commercial interests. RF reports no financial relationships with commercial interests. AG reports no financial relationships with commercial interests. RD reports no financial relationships with commercial interests. LF reports no financial relationships with commercial interests. KT is currently an employee of AstraZeneca (oncology drug development) and was an employee of GlaxoSmithKline in 2013 (urology and thrombosis drug development).
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.